Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone
ClinicalTrials.gov study NCT00911105. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gossypol Acetic Acid With Lenalidomide and Dexamethasone in Treating Patients With Relapsed Symptomatic Multiple Myeloma
ClinicalTrials.gov study NCT02697344. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed And/Or Refractory Multiple Myeloma Patients (CPD)
ClinicalTrials.gov study NCT02185820. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT04776395. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00003401. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating Safety, Tolerability and Clinical Activity of FHND6091 in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT05271682. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors
ClinicalTrials.gov study NCT05698888. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of CAR-BCMA T in Patients With Refractory or Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT03716856. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety, Efficacy, and Pharmacodynamics of a 60-Minute Infusion of Carfilzomib for Progressive Multiple Myeloma
ClinicalTrials.gov study NCT01792102. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of
ClinicalTrials.gov study NCT01753453. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and Lymphoma
ClinicalTrials.gov study NCT04818372. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04036461. IPD Sharing: YES. Countries: 5. Publications: 0.
Efficacy and Safety Study of Pembrolizumab (MK-3475) in Combination With Daratumumab in Participants With Relapsed Refractory Multiple Myeloma (MK-3475-668/KEYNOTE-668)
ClinicalTrials.gov study NCT03221634. IPD Sharing: Not stated. Countries: 6. Publications: 0.
A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Centers for Blood Related Diseases
ClinicalTrials.gov study NCT05742217. IPD Sharing: NO. Countries: 1. Publications: 0.
Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma
ClinicalTrials.gov study NCT00118339. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Pharmacokinetics of Rising Doses of APO010 in Relapsed/Refractory Multiple Myeloma Patients Selected by DRP
ClinicalTrials.gov study NCT03196947. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Clinical Study of NKG2D-CAR-NK Cells for the Treatment of Refractory Recurrent Multiple Myeloma
ClinicalTrials.gov study NCT06379451. IPD Sharing: NO. Countries: 1. Publications: 0.
TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03506802. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00086216. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
ClinicalTrials.gov study NCT05686447. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.